Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 139451, 10 pages
http://dx.doi.org/10.1155/2015/139451
Research Article

Magnolia officinalis Extract Contains Potent Inhibitors against PTP1B and Attenuates Hyperglycemia in db/db Mice

1Edmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun 130012, China
2Academy of Traditional Chinese Medicine and Chinese Medicinal Materials of Jilin Province, Changchun 130012, China
3Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
4Department of Colorectal and Anal Surgery, The Second Hospital, Jilin University, Changchun 130041, China

Received 2 February 2015; Revised 14 April 2015; Accepted 23 April 2015

Academic Editor: Julian Weghuber

Copyright © 2015 Jing Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, IDF Diabetes Atlas, IDF, 6th edition, 2013, http://www.idf.org/diabetesatlas.
  2. World Health Organization, 10 Facts about Diabetes, 2014, http://www.who.int/features/factfiles/diabetes/en/.
  3. B. J. Goldstein, “Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 6, pp. 2474–2480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Lin and Z. J. Sun, “Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes,” British Journal of Pharmacology, vol. 162, no. 3, pp. 597–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. He, L.-F. Zeng, Z.-H. Yu, R. He, S. Liu, and Z.-Y. Zhang, “Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors,” Bioorganic & Medicinal Chemistry, vol. 20, no. 6, pp. 1940–1946, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. N. K. Tonks, C. D. Diltz, and E. H. Fischer, “Purification of the major protein-tyrosine-phosphatases of human placenta,” Journal of Biological Chemistry, vol. 263, no. 14, pp. 6722–6730, 1988. View at Google Scholar · View at Scopus
  7. N. K. Tonks, “PTP1B: from the sidelines to the front lines!,” FEBS Letters, vol. 546, no. 1, pp. 140–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Echwald, H. Bach, H. Vestergaard et al., “A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro,” Diabetes, vol. 51, no. 1, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. J. Goldstein, A. Bittner-Kowalczyk, M. F. White, and M. Harbeck, “Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the GRB2 adaptor protein,” The Journal of Biological Chemistry, vol. 275, no. 6, pp. 4283–4289, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Elchebly, P. Payette, E. Michaliszyn et al., “Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene,” Science, vol. 283, no. 5407, pp. 1544–1548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. L. D. Klaman, O. Boss, O. D. Peroni et al., “Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice,” Molecular and Cellular Biology, vol. 20, no. 15, pp. 5479–5489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. K. H. Thompson, J. Lichter, C. LeBel, M. C. Scaife, J. H. McNeill, and C. Orvig, “Vanadium treatment of type 2 diabetes: a view to the future,” Journal of Inorganic Biochemistry, vol. 103, no. 4, pp. 554–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Liu, “Technology evaluation: ISIS-113715, Isis,” Current Opinion in Molecular Therapeutics, vol. 6, no. 3, pp. 331–336, 2004. View at Google Scholar · View at Scopus
  14. P. Jiří, J. Jiří, and S. Anna, “Expectations of biologically active compounds of the genus Magnolia in biomedicine,” Journal of Applied Biomedicine, vol. 4, pp. 171–178, 2006. View at Google Scholar
  15. X. Liang, W. Meng, T. Niu, Z. Zhao, and G. W. Zhou, “Expression, purification, and crystallization of the catalytic domain of protein tyrosine phosphatase SHP-1,” Journal of Structural Biology, vol. 120, no. 2, pp. 201–203, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Shi, H. Dong, Z. Zhu et al., “Expression of catalytic domain of protein tyrosine phosphatase 1B and preparation of its polyclonal antibody,” Chemical Research in Chinese Universities, vol. 23, no. 2, pp. 204–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhao, P. Bouchard, C. D. Diltz, S.-H. Shen, and E. H. Fischer, “Purification and characterization of a protein tyrosine phosphatase containing SH2 domains,” The Journal of Biological Chemistry, vol. 268, no. 4, pp. 2816–2820, 1993. View at Google Scholar · View at Scopus
  18. Z.-C. Zhu, M. Sun, X.-Y. Zhang et al., “Expression and characterization of catalytic domain of T cell protein tyrosine phosphatase (Delta TC-PTP)—immunohistochemical study of Delta TC-PTP expression in non-small cell lung carcinomas,” Chemical Research in Chinese Universities, vol. 23, no. 3, pp. 289–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Matsuo, A. Bettaieb, N. Nagata, I. Matsuo, H. Keilhack, and F. G. Haj, “Regulation of brown fat adipogenesis by protein tyrosine phosphatase 1B,” PLoS ONE, vol. 6, no. 1, Article ID e16446, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Shirali, S. Z. Bathaie, and M. Nakhjavani, “Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats,” Phytotherapy Research, vol. 27, no. 7, pp. 1042–1047, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. N. J. Bryant, R. Govers, and D. E. James, “Regulated transport of the glucose transporter GLUT4,” Nature Reviews Molecular Cell Biology, vol. 3, no. 4, pp. 267–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. White and C. R. Kahn, “The insulin signaling system,” Journal of Biological Chemistry, vol. 269, no. 1, pp. 1–4, 1994. View at Google Scholar · View at Scopus
  23. K. A. Kenner, E. Anyanwu, J. M. Olefsky, and J. Kusari, “Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling,” The Journal of Biological Chemistry, vol. 271, no. 33, pp. 19810–19816, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Yip, S. Saha, and J. Chernoff, “PTP1B: a double agent in metabolism and oncogenesis,” Trends in Biochemical Sciences, vol. 35, no. 8, pp. 442–449, 2010. View at Google Scholar
  25. A. Maeda, K. Kai, M. Ishii, T. Ishii, and M. Akagawa, “Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice,” Molecular Nutrition & Food Research, vol. 58, no. 6, pp. 1177–1189, 2014. View at Publisher · View at Google Scholar
  26. S. Fukuda, T. Ohta, S. Sakata et al., “Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551,” Diabetes, Obesity and Metabolism, vol. 12, no. 4, pp. 299–306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Q. Wang, D. Ribnicky, X. H. Zhang et al., “An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice,” Journal of Nutritional Biochemistry, vol. 22, no. 1, pp. 71–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-D. Wang, B.-S. Teng, Y.-M. He et al., “Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice,” British Journal of Nutrition, vol. 108, no. 11, pp. 2014–2025, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. E. You-Ten, E. S. Muise, A. Itié et al., “Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice,” Journal of Experimental Medicine, vol. 186, no. 5, pp. 683–693, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. C. M. Taniguchi, B. Emanuelli, and C. R. Kahn, “Critical nodes in signalling pathways: insights into insulin action,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 85–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Hundal, M. Krssak, S. Dufour et al., “Mechanism by which metformin reduces glucose production in type 2 diabetes,” Diabetes, vol. 49, no. 12, pp. 2063–2069, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Haque, J. N. Andersen, A. Salmeen, D. Barford, and N. K. Tonks, “Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity,” Cell, vol. 147, no. 1, pp. 185–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. E. J. Sohn, C.-S. Kim, Y. S. Kim et al., “Effects of magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats,” Life Sciences, vol. 80, no. 5, pp. 468–475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. G. Atanasov, J. N. Wang, S. P. Gu et al., “Honokiol: a non-adipogenic PPARγ agonist from nature,” Biochimica et Biophysica Acta—General Subjects, vol. 1830, no. 10, pp. 4813–4819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-P. Jeon, S.-M. Shim, H.-Y. Nam et al., “Copy number variation at leptin receptor gene locus associated with metabolic traits and the risk of type 2 diabetes mellitus,” BMC Genomics, vol. 11, article 426, 2010. View at Publisher · View at Google Scholar · View at Scopus